Literature DB >> 20199542

Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis.

L Diluvio, M L Romiti, F Angelini, E Campione, P Rossi, J C Prinz, S Chimenti, A Lamioni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20199542     DOI： 10.1111/j.1365-2133.2010.09650.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

Review 1.  Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.

Authors:  Jane Hoyt Buckner
Journal:  Nat Rev Immunol       Date:  2010-12       Impact factor: 53.106

2.  Etanercept downregulates the Th17 pathway and decreases the IL-17+/IL-10+ cell ratio in patients with psoriasis vulgaris.

Authors:  Emiliano Antiga; Walter Volpi; Elisa Cardilicchia; Laura Maggi; Lucia Filì; Cinzia Manuelli; Paola Parronchi; Paolo Fabbri; Marzia Caproni
Journal:  J Clin Immunol       Date:  2012-06-15       Impact factor: 8.317

Review 3.  Stem cell therapy as a potential treatment option for psoriasis.

Authors:  Piyu Parth Naik
Journal:  An Bras Dermatol       Date:  2022-05-27       Impact factor: 2.113

4.  Attenuation of antigen-specific T helper 1 immunity by Neolitsea hiiranensis and its derived terpenoids.

Authors:  Yin-Hua Cheng; Ih-Sheng Chen; Ying-Chi Lin; Chun-Wei Tung; Hsun-Shuo Chang; Chia-Chi Wang
Journal:  PeerJ       Date:  2016-12-07       Impact factor: 2.984

Review 5.  The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part II: The Treg role in skin diseases pathogenesis.

Authors:  Bogusław Nedoszytko; Magdalena Lange; Małgorzata Sokołowska-Wojdyło; Joanna Renke; Piotr Trzonkowski; Michał Sobjanek; Aneta Szczerkowska-Dobosz; Marek Niedoszytko; Aleksandra Górska; Jan Romantowski; Justyna Czarny; Jarosław Skokowski; Leszek Kalinowski; Roman Nowicki
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

Review 6.  Pathogenesis of psoriasis in the "omic" era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbances.

Authors:  Dominik Samotij; Bogusław Nedoszytko; Joanna Bartosińska; Aleksandra Batycka-Baran; Rafał Czajkowski; Iwona T Dobrucki; Lawrence W Dobrucki; Magdalena Górecka-Sokołowska; Anna Janaszak-Jasienicka; Dorota Krasowska; Leszek Kalinowski; Marta Macieja-Stawczyk; Roman J Nowicki; Agnieszka Owczarczyk-Saczonek; Agata Płoska; Dorota Purzycka-Bohdan; Adrianna Radulska; Edyta Reszka; Anna Siekierzycka; Andrzej Słomiński; Radomir Słomiński; Marta Sobalska-Kwapis; Dominik Strapagiel; Aneta Szczerkowska-Dobosz; Justyna Szczęch; Michał Żmijewski; Adam Reich
Journal:  Postepy Dermatol Alergol       Date:  2020-05-05       Impact factor: 1.837
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.